Senior Consultant Cardiologist
National Heart Centre Singapore
Duke-NUS Medical School
CAROLYN LAM SU PING
MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Dr Lam is recognized globally for expertise in heart failure with preserved ejection fraction. She is a world-renown clinical trialist, with her work as part of the global steering committees of PARAGON and EMPEROR-Preserved trials contribution to the first approved treatments for HFpEF to date. She was appointed to the 2021 European Society of Cardiology Heart Failure Guidelines Task Force and has published >350 articles in journals including NEFM, JAMA, Lancet, Circulation and European Heart Journal; being recognized as Clarivate’s Highly cited Researcher 2021-22 in Clinical Medicine. She serves as Associate Editor for Circulation and European Journal of Heart Failure. In the field of MedTech, Dr. Lam is co-founder of Us2.ai, an award-winning startup dedicated to the automation of the fight against heart disease by applying artificial intelligence to echocardiography (ultrasound of the heart).
Disclosure information not submitted.
Friday, October 27, 2023
16:30 – 17:30 EST
Friday, October 27, 2023
16:30 – 16:50 EST